This simple method for sequentially quantifying hypoxanthine (HYP), inosine (INO), and adenosine (ADN) concentrations exploits the H202 peroxidase-catalyzed chemiluminescence of luminol. Though applied here only to tissue and plasma, this method can be adapted to analyze other body fluids. HYP in human plasma was stable for 30 mm in 10 mmol/L EDTA reagent, whereas ADN was slowly converted to INO. Analytical recovery of HYP and INO added to plasma was 102% each; that of ADN was 95%. The within-run mean CVs for determinations of HYP, INO, and ADN at 1 mol/L were 3.46%, 2.65%, and 3.01%; at 10 mol/L they were 2.16%, 1.88%, and 1.63%, respectively. Corresponding between-run CVs were 5.34%, 4.09%, and 4.17%; and 3.43%, 2.40%, and 2.88%, respectively. Bilirubin at a concentration >50 tniol/L The ability to determine the concentrations of such compounds as adenine nucleotides and its breakdown products is valuable in several situations. Metabolites such as adenosine (ADN), inosine (INO), and hypoxanthine (HYP) can cross the cellular membrane and accumulate in blood (1).' In hypoxic or ischemic tissue these molecules may be enzymatically catabolized and irreversibly lost from the nucleotide pool (2). Degradation of purine bases can be a source of oxygen radicals, resulting in tissue injury during organ preservation (3), ischemia (4), and shock (5). Those critically ill patients with the highest concentrations of INO, HYP, or xanthine in plasma have a significantly decreased survival rate (6). In rat brain subjected to anoxia, accumulation of INO and HYP is considered a good indicator of cellular damage (7). For these reasons we wanted to develop a simple, reliable method for determining these metabolites.
Gardiner
(13) measured the purine bases fluorometrically by linking the formation of hydrogen peroxide to the oxidation of thchlorofluorescin to dichlorofluorescein. This method was also enzyme-specific for each metabolite measured, fast enough to be used clinically, and applicable to the luminescence methods we have developed (14) (15) (16) . Formation of H202 in the presence of luminol will result in emission of light, which is measurable with a luininometer. Here we describe a luminescence method for measuring concentrations of ADN, INO, and HYP in tissue and plasma.
MaterIals and Methods
This method is based on the following sequence of enzyme-catalyzed reactions: 
Reaction 2 is driven to the right by the use of phosphate buffer. We measured the light output with a Model A6112 luminometer (Packard Instruments, Downers Grove, IL 60515).
Reagents: All of the following reagents were purchased from Sigma Chemical Co., St. Louis, MO 63178: adenosine deaminase from calf intestinal mucosa (cat. no. A-1155); purine nucleoside phosphorylase from calf spleen (N-3003); xanthine oxidase from buttermilk (X-4500); peroxidase from horseradish (P-8375); uricase from porcine liver, EC 1.7.3.3 (U-3377); bilirubin oxidase from Myrothecium verrucoria, EC 1.
(B-0390); HYP (H-9377); INO (1-4125); ADN (A-7636); uric acid (U-2875); luminol (A-8511); and bilirubin (B-4126).

Extraction:
We extracted the compounds from blood plasma as previously described (14). In brief, 3 mL of venous or arterial blood, collected at room temperature into disodium EDTA (final concentration 10 mmol/L), was centrifuged without delay (5000 x g, 0#{176}C, 3 mm). We removed part of the plasma layer and mixed it with an equal volume and centrifuged at 5000 x g at 0#{176}C for 15 miii. All subsequent centrifugations in this extraction were performed in the same manner. The supernate was separated and 0.5 mL of the perchloric acid reagent was added to the pellet, mixed well, and centrifuged.
The two supernates were combined and the pH was adjusted to 7.0 by adding buffer containing 0.4 mol of imidazole, 0.3 mol of KC1, and 1.5 mol of KOH per liter. The resulting precipitate was removed by centrifuging and the samples were stored at -80 #{176}C (17) .
Luminol: The optimal pH for the peroxidase-catalyzed Let the mixture reactfor 20 mm at room temperature to eliminate the uric acid.
To all cuvettes then add 175 pL of the luminol solution and let stand for 5 miii to stabilize to zero background. 
Results
Standard curve: Figure 4 
Interference:
We assessedthe possibility of interference in the analysis for one purine by the presence of a high concentration of the other two. As Table 1 shows, the deviation within each purine standard alone, and in the presence of the other two, 20 rzmoIJL each, was negligible. When analyzing all three purines, we soon discovered that the slope of the standard curve for ADN was lower than anticipated. Investigations revealed that the purune-nucleoside phosphorylase reagent was contaminated with adenosine deaminase, whereas the xanthine oxidase was not (Table 2 ). This contamination can partly be controlled by analyzing only six samples at a time in the series instead of the whole set ( Table 3 ). The shorter timed run gives results in better agreement with a control set. When only HYP or INO were being measured, the six-sample analysis scheme was not necessary. Table 5 ). The HYP in plasma treated with EDTA was found to be stable during 30 mm of standing, whereas the concentration of ADN decreased by 63% and INO increased by 57%. The sum of INO plus ADN at each designated time was relatively constant, suggesting that ADN was being mainly degraded to INO.
Accuracy:
The precision of a single sample was assessed by extracting two human control plasma and adjusting one to 1.0 molJL, the other to 10 mol/L for each of the three purines. Each sample was then measured 20 times as described. The within-run mean coefficients of variation (CVs) for the determination of HYP, INO, and ADN at 1 moIJL were 3.46%, 2.65%, and 3.01%; at 10 zmol/L they were 2.16%, 1.88%, and 1.63%, respectively. We evaluated between-run precision by assaying the same two samples on 20 separate days. The day-to-day mean CVs for HYP, INO, and ADN at 1 mol/L were 5.34%, 4.09%, and 4.17%, and at 10 p.mol/L they were 3.43%, 2.40%, and 2.88%, respectively.
Analytical recovery of HYP, INO, and ADN was measured by adding known amounts to human plasma ( LumInescence (x 100) rate suggests that no serious error was introduced in the procedure.
DIscussion
Adenosine deaminase has a slower reaction rate than does nucleoside phosphorylaseor xanthine oxidase. Hence, in the specified reaction interval between 2 and 20s it gives a lower luminescence reading. Adjusting the recording time would result in similar luminescence for the purines, but the assay would be prolonged. The present method is in plasma and other body fluids ranges between 20% and 45% and decreases to between 5% and 12% in hypoxia (29, Insufficient purities of enzymes in a reacting sequence can lead to values that are either too high or too low. We 30). The inability to separate them is less critical when one is evaluating tissue injury caused by oxygen radical formafound that our nucleoside phosphorylase was contaminated tion, because both metabolites are involved. with adenosine deaminase. The problem was partly remeIn human plasma collected in 10 mmolJL EDTA, the died by analyzing only six samples per run, instead of the HYP concentration remained stable during the 30-mm total, and repeating the six-sample runs until all the measurement period. This could be explained by the lack of samples were analyzed. In our study, xanthine oxidase was xanthine oxidase in human blood (31). In contrast, ADN shown to be free of adenosine deaminase (Table 2) . Nudewas gradually converted to INO. There is ample adenosine oside phosphorylase is not specific for inosine; it can also deaminase, the enzyme responsible for this action, in hydrolyze guanosineto guanine (28). This problem may not plasma (32). Accordingly, fast extraction of plasma is very be serious as long as enzymes used in the reaction do not important.
Once the plasma enzymes are precipitated with contain guanase, which produces xanthine from guanine.
an equal volume of ethanol/water (96/4 by vol) and reSigma's nucleoside phosphorylase contains <0.01% guamoved, the nucleotides, nucleosides, and purine bases nase. Their adenosine deaminase (cat. no. A 1155) may change little with time when the samples were kept in iced deaminate 5'-AMP at a rate approximately 0.5% of enzyme water. Because the assay is done at ambient temperature, activity (specified by Sigma) but, because of the short the standards and samples should be equally timed. Anenzyme reaction time in this method and because the other major route of adenosine removal from blood is by adenosine reaction is last in the series, this degree of uptake into erythrocytes and incorporation into adenine enzyme contamination appears not to be significant. nucleoside by adenosine kinas#{233}. Addition of dipyridamole The fluorometric, luminescence, and Po2 methods all have one disadvantage that HPLC does not: the HYP nearly abolished this loss. Five minutes after this drug was added, 90% of the nucleoside was still present in the plasma cannot be separated from xanthine, because both are catab-(10). This dipyridamole extraction method was not used in olized by xanthine oxidase to uric acid, HYP being first the present procedure because of possible interference with converted to xanthine and then to uric acid. The measured other metabolic evaluations. Its use needs further study.
value for HYP in this assay is a combination of both. HYP Table 9 shows values for HYP, INO, and ADN in venous produces twice the light output that xanthine does. This plasma from the cubital veins of a mixed volunteergroup, HYP/xanthine ratio of 2.0 is clearly shown in Table 7 .
ages 20 to 40. Values for arterial plasma of rabbits com- Table 8 shows the variation of light output when the pared with the same rabbits in late E. coli endotoxin shock concentration of HYP plus xanthine was kept constant are also displayed. These animals were shocked with an while the ratio was varied. In further evaluating the intravenous injection of the endotoxin, 4 mg per kilogram presence of INO and ADN, both kept constant at 5 pmolfL of body weight. Plasma was sampled from the left carotid in all cuvettes, we saw only small variations in light artery and muscle samples from the hind leg. Late shock output. Therefore, in this method the inability to separate was estimated by a decrease in arterial pressure, low HYP from xanthine does not interfere in the determinaplatelet count, and decisive changes in blood gases and tions of INO and ADN, but the value of HYP will be high blood pH (33, 34) . The increase of all three purines in owing to the presence of xanthine.The xanthine/HYP ratio plasma in late shock coincided with a similar increase in muscle from the same group of rabbits.
In the last few years, most of reported measurements of HYP, INO, or ADN were performed by HPLC (Table 10) .
Our value for HYP in human venous plasma compares with the higher of the two human values displayed in Table  10 , although we must take into consideration that we were measuring both HYP and xanthine, whereas HPLC measures only the former. We could find only one recent evaluation of both plasma INO and ADN in humans in which HPLC was used. Our plasma inosine value was similar but that for ADN was much lower, 0. This method is applicable to small-animal studies where the amount of blood volume is critical.
Only 40 pL of sample is needed for measurement of all three purines. The major disadvantages of the method are the inability to separate HYP from xanthine and the interference of allopurinol and oxygen radical quenchers, neither of which is likely to occur in HPLC. Advantages over HPLC include simplicity, ease of operation, accuracy, and shorter assay time.
